JP2025506203A5 - - Google Patents
Info
- Publication number
- JP2025506203A5 JP2025506203A5 JP2024547850A JP2024547850A JP2025506203A5 JP 2025506203 A5 JP2025506203 A5 JP 2025506203A5 JP 2024547850 A JP2024547850 A JP 2024547850A JP 2024547850 A JP2024547850 A JP 2024547850A JP 2025506203 A5 JP2025506203 A5 JP 2025506203A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- antibody
- her2
- polypeptide
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263267755P | 2022-02-09 | 2022-02-09 | |
| US63/267,755 | 2022-02-09 | ||
| PCT/US2023/062260 WO2023154780A1 (en) | 2022-02-09 | 2023-02-09 | Anti-her2/neu antibodies and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506203A JP2025506203A (ja) | 2025-03-07 |
| JP2025506203A5 true JP2025506203A5 (enExample) | 2026-03-27 |
Family
ID=86054158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547850A Pending JP2025506203A (ja) | 2022-02-09 | 2023-02-09 | 抗ｈｅｒ２／ｎｅｕ抗体および使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250180565A1 (enExample) |
| EP (1) | EP4476265A1 (enExample) |
| JP (1) | JP2025506203A (enExample) |
| CN (1) | CN119053627A (enExample) |
| WO (1) | WO2023154780A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| WO2022221877A2 (en) * | 2021-04-16 | 2022-10-20 | Martell Diagnostic Laboratories, Inc. | Lateral flow analysis and breast cancer |
-
2023
- 2023-02-09 WO PCT/US2023/062260 patent/WO2023154780A1/en not_active Ceased
- 2023-02-09 US US18/837,130 patent/US20250180565A1/en active Pending
- 2023-02-09 CN CN202380027645.1A patent/CN119053627A/zh active Pending
- 2023-02-09 JP JP2024547850A patent/JP2025506203A/ja active Pending
- 2023-02-09 EP EP23718550.9A patent/EP4476265A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022087293A1 (en) | Methods and systems for detecting coronavirus | |
| CN102971343B (zh) | 用于癌症诊断和/或预后的新型抗体 | |
| JP2018511319A5 (enExample) | ||
| EP2363471B1 (en) | Immunoassay method for human cxcl1 protein | |
| JP2018518151A5 (enExample) | ||
| JP2023527937A5 (enExample) | ||
| JP2009541204A5 (enExample) | ||
| CN112105644B (zh) | 针对人pd-l1和pd-l2的双重特异性抗体及其使用方法 | |
| JP2016500659A5 (enExample) | ||
| JP7557023B2 (ja) | 多発性骨髄腫におけるｍタンパク質反応の臨床評価 | |
| CN113214393A (zh) | Il-6抗体或其抗原结合片段及包含其的检测试剂盒 | |
| CN108700586A (zh) | 用于评估癌症发生的风险的组合物和方法 | |
| JP2024534348A5 (enExample) | ||
| KR102058150B1 (ko) | 담도 세포에서 메티오닐-티알엔에이 합성효소를 이용한 담도암 진단 방법 | |
| JP2025506203A5 (enExample) | ||
| US11009507B2 (en) | Methods and diagnostics for cancer detection and treatment monitoring | |
| CN111316102A (zh) | 使用甲硫氨酰-tRNA合成酶诊断胰腺癌的方法以及利用其的胰腺癌诊断试剂盒 | |
| JP2023527771A (ja) | 抗ヒトｌａｇ－３抗体および免疫組織化学（ｉｈｃ）でのその使用 | |
| JP2020515286A5 (enExample) | ||
| JP7593669B2 (ja) | コンパニオン診断用バイオマーカー組成物およびこれを含むコンパニオン診断用キット | |
| JP2024544885A5 (enExample) | ||
| CN116836291B (zh) | 抗cd47-cldn18.2双特异性抗体的抗独特型抗体及其制备方法和应用 | |
| TWI869740B (zh) | 一種體外檢測ｓＴＮＦＲ２蛋白濃度的方法及其檢測試劑和檢測試劑盒 | |
| CN112724253B (zh) | 抗人穹窿体蛋白的抗体及其应用 | |
| JP2025510594A5 (enExample) |